Cyclic modulation of enzymes of pyrimidine nucleotide biosynthesis precedes sialoglycoconjugate changes during 2-acetylaminofluorene-induced hepatocarcinogenesis in the rat

Three enzymatic activities associated with pyrimidine nucleotide biosynthesis were monitored at weekly or bi-weekly intervals during 2-acetylaminofluorene- (0.025% in a Farber Basal Carcinogenic diet) induced hepatocarcinogenesis in the rat. Dihydroorotate dehydrogenase, the fourth of six enzymes in...

Full description

Saved in:
Bibliographic Details
Published inBiochimica et biophysica acta Vol. 800; no. 2; pp. 194 - 201
Main Authors Elliott, William L., Sawick, David P., DeFrees, Shawn A., Heinstein, Peter F., Cassady, John M., James Morré, D.
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier B.V 30.07.1984
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Three enzymatic activities associated with pyrimidine nucleotide biosynthesis were monitored at weekly or bi-weekly intervals during 2-acetylaminofluorene- (0.025% in a Farber Basal Carcinogenic diet) induced hepatocarcinogenesis in the rat. Dihydroorotate dehydrogenase, the fourth of six enzymes in de novo pyrimidine biosynthesis, decline in activity while UDP kinase and CTP synthetase showed sequential increases in activity. The alterations in activity appeared to be cyclic, followed by a full or partial return to control values. Three full cycles were monitored. The first cycle preceded nodule formation. The second cycle accompanied nodule formation and preceded sialoglycoconjugate changes reported previously. The third cycle accompanied the early glycoconjugate changes. The cyclic pattern was reproducible in three separate experiments. In each cycle, the order of events was as follows: decrease in dihydroorotate dehydrogenase, sequential increases in UDP kinase, CTP synthetase and CMPsialic acid synthase, and finally increases in the enzyme lactosylceramide: CMPsialic acid sialyltransferase, lipid-soluble sialic acid and total sialic acid. In livers of animals fed 1.87% of the hepatotoxin, 4-acetamidophenol, no biochemical alterations resembling those induced by 2-acetylaminofluorene were obtained, despite acute centrilobular necrosis of the livers. The findings point to a biochemical cascade beginning with administration of carcinogen and continuing through the development of hyperplastic nodules and of frank carcinomas resulting not from hepatotoxicity but as events associated with the hepatocarcinogenic progression.
AbstractList Three enzymatic activities associated with pyrimidine nucleotide biosynthesis were monitored at weekly or bi-weekly intervals during 2-acetylaminofluorene- (0.025% in a Farber Basal Carcinogenic diet) induced hepatocarcinogenesis in the rat. Dihydroorotate dehydrogenase, the fourth of six enzymes in de novo pyrimidine biosynthesis, declined in activity while UDP kinase and CTP synthetase showed sequential increases in activity. The alterations in activity appeared to be cyclic, followed by a full or partial return to control values. Three full cycles were monitored. The first cycle preceded nodule formation. The second cycle accompanied nodule formation and preceded sialoglycoconjugate changes reported previously. The third cycle accompanied the early glycoconjugate changes. The cyclic pattern was reproducible in three separate experiments. In each cycle, the order of events was as follows: decrease in dihydroorotate dehydrogenase, sequential increases in UDP kinase, CTP synthetase and CMPsialic acid synthase, and finally increases in the enzyme lactosylceramide: CMPsialic acid sialyltransferase, lipid-soluble sialic acid and total sialic acid. In livers of animals fed 1.87% of the hepatotoxin, 4-acetamidophenol, no biochemical alterations resembling those induced by 2-acetylaminofluorene were obtained, despite acute centrilobular necrosis of the livers. The findings point to a biochemical cascade beginning with administration of carcinogen and continuing through the development of hyperplastic nodules and of frank carcinomas resulting not from hepatotoxicity but as events associated with the hepatocarcinogenic progression.
Three enzymatic activities associated with pyrimidine nucleotide biosynthesis were monitored at weekly or bi-weekly intervals during 2-acetylaminofluorene- (0.025% in a Farber Basal Carcinogenic diet) induced hepatocarcinogenesis in the rat. Dihydroorotate dehydrogenase, the fourth of six enzymes in de novo pyrimidine biosynthesis, decline in activity while UDP kinase and CTP synthetase showed sequential increases in activity. The alterations in activity appeared to be cyclic, followed by a full or partial return to control values. Three full cycles were monitored. The first cycle preceded nodule formation. The second cycle accompanied nodule formation and preceded sialoglycoconjugate changes reported previously. The third cycle accompanied the early glycoconjugate changes. The cyclic pattern was reproducible in three separate experiments. In each cycle, the order of events was as follows: decrease in dihydroorotate dehydrogenase, sequential increases in UDP kinase, CTP synthetase and CMPsialic acid synthase, and finally increases in the enzyme lactosylceramide: CMPsialic acid sialyltransferase, lipid-soluble sialic acid and total sialic acid. In livers of animals fed 1.87% of the hepatotoxin, 4-acetamidophenol, no biochemical alterations resembling those induced by 2-acetylaminofluorene were obtained, despite acute centrilobular necrosis of the livers. The findings point to a biochemical cascade beginning with administration of carcinogen and continuing through the development of hyperplastic nodules and of frank carcinomas resulting not from hepatotoxicity but as events associated with the hepatocarcinogenic progression.
Three enzymatic activities associated with pyrimidine nucleotide biosynthesis were monitored at weekly or bi-weekly intervals during 2-acetylaminofluorene- (0.025% in a Farber Basal Carcinogenic diet) induced hepatocarcinogenesis in the rat. Dihydroorotate dehydrogenase, the fourth of six enzymes in de novo pyrimidine biosynthesis, declined in activity while UDP kinase and CTP synthetase showed sequential increases in activity. The alterations in activity appeared to be cyclic, followed by a full or partial return to control values. Three full cycles were monitored. The first cycle preceded nodule formation. The second cycle accompanied nodule formation and preceded sialoglycoconjugate changes reported previously. The third cycle accompanied the early glycoconjugate changes. The cyclic pattern was reproducible in three separate experiments. In each cycle, the order of events was as follows: decrease in dihydroorotate dehydrogenase, sequential increases in UDP kinase, CTP synthetase and CMPsialic acid synthase, and finally increases in the enzyme lactosylceramide: CMPsialic acid sialyltransferase, lipid-soluble sialic acid and total sialic acid. In livers of animals fed 1.87% of the hepatotoxin, 4-acetamidophenol, no biochemical alterations resembling those induced by 2-acetylaminofluorene were obtained, despite acute centrilobular necrosis of the livers. The findings point to a biochemical cascade beginning with administration of carcinogen and continuing through the development of hyperplastic nodules and of frank carcinomas resulting not from hepatotoxicity but as events associated with the hepatocarcinogenic progression.Three enzymatic activities associated with pyrimidine nucleotide biosynthesis were monitored at weekly or bi-weekly intervals during 2-acetylaminofluorene- (0.025% in a Farber Basal Carcinogenic diet) induced hepatocarcinogenesis in the rat. Dihydroorotate dehydrogenase, the fourth of six enzymes in de novo pyrimidine biosynthesis, declined in activity while UDP kinase and CTP synthetase showed sequential increases in activity. The alterations in activity appeared to be cyclic, followed by a full or partial return to control values. Three full cycles were monitored. The first cycle preceded nodule formation. The second cycle accompanied nodule formation and preceded sialoglycoconjugate changes reported previously. The third cycle accompanied the early glycoconjugate changes. The cyclic pattern was reproducible in three separate experiments. In each cycle, the order of events was as follows: decrease in dihydroorotate dehydrogenase, sequential increases in UDP kinase, CTP synthetase and CMPsialic acid synthase, and finally increases in the enzyme lactosylceramide: CMPsialic acid sialyltransferase, lipid-soluble sialic acid and total sialic acid. In livers of animals fed 1.87% of the hepatotoxin, 4-acetamidophenol, no biochemical alterations resembling those induced by 2-acetylaminofluorene were obtained, despite acute centrilobular necrosis of the livers. The findings point to a biochemical cascade beginning with administration of carcinogen and continuing through the development of hyperplastic nodules and of frank carcinomas resulting not from hepatotoxicity but as events associated with the hepatocarcinogenic progression.
Author DeFrees, Shawn A.
Heinstein, Peter F.
Elliott, William L.
James Morré, D.
Sawick, David P.
Cassady, John M.
Author_xml – sequence: 1
  givenname: William L.
  surname: Elliott
  fullname: Elliott, William L.
  organization: Department of Medicinal Chemistry and Pharmacognosy, Purdue University, West Lafayette, IN 47907 USA
– sequence: 2
  givenname: David P.
  surname: Sawick
  fullname: Sawick, David P.
  organization: Department of Medicinal Chemistry and Pharmacognosy, Purdue University, West Lafayette, IN 47907 USA
– sequence: 3
  givenname: Shawn A.
  surname: DeFrees
  fullname: DeFrees, Shawn A.
  organization: Department of Medicinal Chemistry and Pharmacognosy, Purdue University, West Lafayette, IN 47907 USA
– sequence: 4
  givenname: Peter F.
  surname: Heinstein
  fullname: Heinstein, Peter F.
  organization: Department of Medicinal Chemistry and Pharmacognosy, Purdue University, West Lafayette, IN 47907 USA
– sequence: 5
  givenname: John M.
  surname: Cassady
  fullname: Cassady, John M.
  organization: Department of Medicinal Chemistry and Pharmacognosy, Purdue University, West Lafayette, IN 47907 USA
– sequence: 6
  givenname: D.
  surname: James Morré
  fullname: James Morré, D.
  organization: Department of Medicinal Chemistry and Pharmacognosy, Purdue University, West Lafayette, IN 47907 USA
BackLink https://www.ncbi.nlm.nih.gov/pubmed/6331524$$D View this record in MEDLINE/PubMed
BookMark eNqFkc2KFDEUhYOMjD2tb6CQleiiNPWTVJULQZrxBwbc6Dqkbm51Z0glZZIaKJ_Jh5z0dOvChWaThHPuufCdK3LhvENCnpfsTclK8ZbVrCmaUvBXXfO6Z0ywQjwim7Jrq6LL3wuy-WN5Qq5ivGX58J5fkktR1yWvmg35tVvBGqCT14tVyXhH_UjR_VwnjMfnvAYzGW0cUreARZ-MRjoYH1eXDhhNpHNAQJ3t0Sjr93YFD97dLnuVkMJBuX3W9BKM29OqUIBptWoyzo928QEdFsbpJUfQA84qeVABsrrPyjHeOJoX0aDSU_J4VDbis_O9Jd8_Xn_bfS5uvn76svtwU0DN21QI4GOnh1YLGLQSjFet5rxv-dh3I-t7qETVVTCUzTCIkgvAGgeVFRhHoXqst-TlKXcO_seCMcnJREBrlUO_RNmVGWnVNNn44mxchgm1nDMrFVZ5xpv1dycdgo8x4CjBpAfKKShjZcnksUp57Ekee5JdIx-qzBFb0vw1_Dv-P2PvT2OYCd0ZDDKCQZfxmtxTktqbfwfcAxfiu6E
CitedBy_id crossref_primary_10_1016_0006_2952_88_90060_3
crossref_primary_10_1039_c3cp52692e
crossref_primary_10_1016_0024_3205_88_90390_6
crossref_primary_10_1016_S0021_9258_19_50416_1
crossref_primary_10_1016_0006_2952_92_90289_U
crossref_primary_10_1021_jp065034t
crossref_primary_10_1039_C5CP02016F
crossref_primary_10_1016_0006_2952_90_90657_7
crossref_primary_10_1021_jp512860r
Cites_doi 10.1016/0065-2571(80)90005-9
10.1093/jnci/60.6.1313
10.1016/0005-2760(84)90314-X
10.1016/0014-5793(70)80523-3
10.1159/000224817
10.1016/S0021-9258(19)52451-6
10.1016/S0304-3835(79)80018-X
10.1093/jnci/60.6.1329
10.1016/0065-2571(74)90023-5
10.1126/science.185697
10.1016/0041-008X(71)90328-0
10.1002/jss.400090203
10.1038/271071a0
10.1016/S0021-9258(18)63103-5
10.1016/0065-2571(78)90064-X
10.1038/253567a0
10.1126/science.182.4115.935
ContentType Journal Article
Copyright 1984
Copyright_xml – notice: 1984
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1016/0304-4165(84)90060-6
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Chemistry
Biology
EISSN 1872-8006
EndPage 201
ExternalDocumentID 6331524
10_1016_0304_4165_84_90060_6
0304416584900606
Genre Journal Article
GroupedDBID ---
--K
--M
.~1
0R~
1B1
1RT
1~.
1~5
23N
3O-
4.4
457
4G.
53G
5GY
5RE
5VS
7-5
71M
8P~
9JM
AACTN
AAEDT
AAEDW
AAIAV
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AAXUO
ABEFU
ABFNM
ABGSF
ABMAC
ABUDA
ABXDB
ABYKQ
ACDAQ
ACIUM
ACRLP
ADBBV
ADEZE
ADMUD
ADUVX
AEBSH
AEHWI
AEKER
AFKWA
AFTJW
AFXIZ
AGHFR
AGRDE
AGUBO
AGYEJ
AHHHB
AIEXJ
AIKHN
AITUG
AJBFU
AJOXV
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
CS3
DOVZS
EBS
EFJIC
EFLBG
EJD
EO8
EO9
EP2
EP3
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HLW
HVGLF
HZ~
IHE
J1W
KOM
LX3
M41
MO0
N9A
O-L
O9-
OAUVE
OHT
OZT
P-8
P-9
PC.
Q38
R2-
ROL
RPZ
SBG
SCC
SDF
SDG
SDP
SES
SEW
SPCBC
SSU
SSZ
T5K
UQL
WH7
WUQ
XJT
XPP
~G-
AAHBH
AATTM
AAXKI
AAYWO
AAYXX
ABWVN
ACRPL
ACVFH
ADCNI
ADNMO
AEIPS
AEUPX
AFJKZ
AFPUW
AGCQF
AGQPQ
AGRNS
AIGII
AIIUN
AKBMS
AKRWK
AKYEP
ANKPU
APXCP
BNPGV
CITATION
SSH
-~X
.55
.GJ
ABJNI
AFFNX
AI.
CGR
CUY
CVF
ECM
EIF
F5P
H~9
MVM
NPM
PKN
TWZ
VH1
X7M
Y6R
YYP
ZGI
~KM
7X8
ID FETCH-LOGICAL-c357t-6c5f8db7d6cbda60527d55975f98f099c26282cb14bb6156ce3ebaf09cff6a9e3
ISSN 0304-4165
0006-3002
IngestDate Fri Jul 11 03:14:14 EDT 2025
Wed Feb 19 02:36:30 EST 2025
Tue Jul 01 03:49:07 EDT 2025
Thu Apr 24 22:55:27 EDT 2025
Fri Feb 23 02:36:17 EST 2024
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords Sialoglycoconjugate change
Pyrimidine nucleotide synthesis
Carcinogenesis (Rat liver)
Acetylaminofluorene
Language English
License https://www.elsevier.com/tdm/userlicense/1.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c357t-6c5f8db7d6cbda60527d55975f98f099c26282cb14bb6156ce3ebaf09cff6a9e3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 6331524
PQID 81165244
PQPubID 23479
PageCount 8
ParticipantIDs proquest_miscellaneous_81165244
pubmed_primary_6331524
crossref_citationtrail_10_1016_0304_4165_84_90060_6
crossref_primary_10_1016_0304_4165_84_90060_6
elsevier_sciencedirect_doi_10_1016_0304_4165_84_90060_6
ProviderPackageCode CITATION
AAYXX
PublicationCentury 1900
PublicationDate 1984-07-30
PublicationDateYYYYMMDD 1984-07-30
PublicationDate_xml – month: 07
  year: 1984
  text: 1984-07-30
  day: 30
PublicationDecade 1980
PublicationPlace Netherlands
PublicationPlace_xml – name: Netherlands
PublicationTitle Biochimica et biophysica acta
PublicationTitleAlternate Biochim Biophys Acta
PublicationYear 1984
Publisher Elsevier B.V
Publisher_xml – name: Elsevier B.V
References Goldenthal (BIB28) 1971
Williams, Morris, Weber (BIB18) 1975; 253
Otal-Brun, Webb (BIB13) 1979; 6
Weber, Olah, Lui, Kizaki, Tzeng, Takeda (BIB15) 1980; 18
Cheema, Yogeeswaran, Morris, Murray (BIB6) 1970; 11
Fishman, Brady (BIB1) 1976; 194
Weber, Shiotani, Kizaki, Tzeng, Williams, Gladstone (BIB16) 1978; 16
Mitchell, Jollow, Potter, Davis, Gillett, Brodie (BIB25) 1973; 187
Merritt, Morré, Keenan (BIB9) 1978; 60
Epstein, Ito, Merkow, Farber (BIB20) 1967; 27
Keenan, Morré (BIB7) 1973; 182
Lowry, Rosebrough, Farr, Randall (BIB23) 1951; 193
Siddiqui, Hakomori (BIB8) 1970; 30
Sweeney, Hoffman (BIB17) 1973; 33
Higgins, Anderson (BIB21) 1931; 12
Richardson, Baker, Morré, Keenan (BIB4) 1975; 417
Kizaki, Williams, Morris, Weber (BIB12) 1980; 40
Williams, Davis (BIB27) 1977; 18
Keppler (BIB29) 1977; 37
Williams, Kizaki, Weber, Morris (BIB19) 1978; 271
Hakomori (BIB2) 1975; 417
Veselý, Ĉihák (BIB30) 1973; 28
Creek, Walter, Evers, Yeo, Elliott, Heinstein, Morré, Morré (BIB10) 1984; 793
Thorgeisson, Felton, Nebert (BIB26) 1975; 11
Savage, Weinfeld (BIB22) 1970; 245
Merritt, Richardson, Keenan, Morré (BIB5) 1978; 60
Ahmed, Baker (BIB11) 1980; 40
Finco, Duncan, Schall, Prasse (BIB24) 1975; 166
Morré, Kloppel, Merritt, Keenan (BIB3) 1978; 9
Sweeney, Parton, Hoffman (BIB14) 1974; 12
Weber (10.1016/0304-4165(84)90060-6_BIB15) 1980; 18
Hakomori (10.1016/0304-4165(84)90060-6_BIB2) 1975; 417
Sweeney (10.1016/0304-4165(84)90060-6_BIB14) 1974; 12
Higgins (10.1016/0304-4165(84)90060-6_BIB21) 1931; 12
Richardson (10.1016/0304-4165(84)90060-6_BIB4) 1975; 417
Keenan (10.1016/0304-4165(84)90060-6_BIB7) 1973; 182
Weber (10.1016/0304-4165(84)90060-6_BIB16) 1978; 16
Williams (10.1016/0304-4165(84)90060-6_BIB18) 1975; 253
Lowry (10.1016/0304-4165(84)90060-6_BIB23) 1951; 193
Veselý (10.1016/0304-4165(84)90060-6_BIB30) 1973; 28
Siddiqui (10.1016/0304-4165(84)90060-6_BIB8) 1970; 30
Cheema (10.1016/0304-4165(84)90060-6_BIB6) 1970; 11
Kizaki (10.1016/0304-4165(84)90060-6_BIB12) 1980; 40
Finco (10.1016/0304-4165(84)90060-6_BIB24) 1975; 166
Keppler (10.1016/0304-4165(84)90060-6_BIB29) 1977; 37
Williams (10.1016/0304-4165(84)90060-6_BIB27) 1977; 18
Fishman (10.1016/0304-4165(84)90060-6_BIB1) 1976; 194
Sweeney (10.1016/0304-4165(84)90060-6_BIB17) 1973; 33
Ahmed (10.1016/0304-4165(84)90060-6_BIB11) 1980; 40
Merritt (10.1016/0304-4165(84)90060-6_BIB9) 1978; 60
Williams (10.1016/0304-4165(84)90060-6_BIB19) 1978; 271
Thorgeisson (10.1016/0304-4165(84)90060-6_BIB26) 1975; 11
Otal-Brun (10.1016/0304-4165(84)90060-6_BIB13) 1979; 6
Creek (10.1016/0304-4165(84)90060-6_BIB10) 1984; 793
Mitchell (10.1016/0304-4165(84)90060-6_BIB25) 1973; 187
Merritt (10.1016/0304-4165(84)90060-6_BIB5) 1978; 60
Morré (10.1016/0304-4165(84)90060-6_BIB3) 1978; 9
Epstein (10.1016/0304-4165(84)90060-6_BIB20) 1967; 27
Savage (10.1016/0304-4165(84)90060-6_BIB22) 1970; 245
Goldenthal (10.1016/0304-4165(84)90060-6_BIB28) 1971
References_xml – volume: 16
  start-page: 3
  year: 1978
  end-page: 19
  ident: BIB16
  publication-title: Adv. Enzyme Reg.
– volume: 12
  start-page: 186
  year: 1931
  end-page: 202
  ident: BIB21
  publication-title: Arch. Pathol.
– volume: 166
  start-page: 469
  year: 1975
  end-page: 476
  ident: BIB24
  publication-title: J. Am. Vet. Med. Assoc.
– volume: 9
  start-page: 157
  year: 1978
  end-page: 177
  ident: BIB3
  publication-title: J. Supramol. Struct.
– volume: 11
  start-page: 181
  year: 1970
  end-page: 184
  ident: BIB6
  publication-title: FEBS Lett.
– volume: 28
  start-page: 204
  year: 1973
  end-page: 226
  ident: BIB30
  publication-title: Oncology
– volume: 793
  start-page: 133
  year: 1984
  end-page: 140
  ident: BIB10
  publication-title: Biochim. Biophys. Acta
– volume: 182
  start-page: 935
  year: 1973
  end-page: 937
  ident: BIB7
  publication-title: Science
– volume: 60
  start-page: 1313
  year: 1978
  end-page: 1327
  ident: BIB5
  publication-title: J. Natl. Can. Inst.
– volume: 40
  start-page: 3559
  year: 1980
  end-page: 3563
  ident: BIB11
  publication-title: Cancer Res.
– volume: 6
  start-page: 39
  year: 1979
  end-page: 44
  ident: BIB13
  publication-title: Cancer Lett.
– volume: 18
  start-page: 3
  year: 1980
  end-page: 26
  ident: BIB15
  publication-title: Adv. Enzyme Reg.
– volume: 30
  start-page: 2930
  year: 1970
  end-page: 2936
  ident: BIB8
  publication-title: Cancer Res.
– volume: 40
  start-page: 3921
  year: 1980
  end-page: 3927
  ident: BIB12
  publication-title: Cancer Res.
– volume: 245
  start-page: 2529
  year: 1970
  end-page: 2534
  ident: BIB22
  publication-title: J. Biol. Chem.
– volume: 27
  start-page: 1702
  year: 1967
  end-page: 1711
  ident: BIB20
  publication-title: Cancer Res.
– volume: 18
  start-page: 27
  year: 1977
  end-page: 40
  ident: BIB27
  publication-title: Proc. Eur. Soc. Toxicol.
– volume: 271
  start-page: 71
  year: 1978
  end-page: 72
  ident: BIB19
  publication-title: Nature
– volume: 60
  start-page: 1329
  year: 1978
  end-page: 1337
  ident: BIB9
  publication-title: J. Natl. Can. Inst.
– volume: 12
  start-page: 385
  year: 1974
  end-page: 396
  ident: BIB14
  publication-title: Adv. Enzyme Reg.
– volume: 253
  start-page: 567
  year: 1975
  end-page: 569
  ident: BIB18
  publication-title: Nature
– volume: 37
  start-page: 911
  year: 1977
  end-page: 917
  ident: BIB29
  publication-title: Cancer Res.
– volume: 11
  start-page: 159
  year: 1975
  end-page: 165
  ident: BIB26
  publication-title: Mol. Pharmacol.
– volume: 33
  start-page: 394
  year: 1973
  end-page: 396
  ident: BIB17
  publication-title: Cancer Res.
– volume: 193
  start-page: 265
  year: 1951
  end-page: 275
  ident: BIB23
  publication-title: J. Biol. Chem.
– volume: 417
  start-page: 55
  year: 1975
  end-page: 89
  ident: BIB2
  publication-title: Biochim. Biophys. Acta
– volume: 187
  start-page: 185
  year: 1973
  end-page: 194
  ident: BIB25
  publication-title: J. Pharmacol. Exp. Therap.
– volume: 417
  start-page: 175
  year: 1975
  end-page: 186
  ident: BIB4
  publication-title: Biochim. Biophys. Acta
– volume: 194
  start-page: 906
  year: 1976
  end-page: 915
  ident: BIB1
  publication-title: Science
– start-page: 185
  year: 1971
  end-page: 207
  ident: BIB28
  publication-title: Tox. Appl. Pharmacol.
– volume: 18
  start-page: 3
  year: 1980
  ident: 10.1016/0304-4165(84)90060-6_BIB15
  publication-title: Adv. Enzyme Reg.
  doi: 10.1016/0065-2571(80)90005-9
– volume: 60
  start-page: 1313
  year: 1978
  ident: 10.1016/0304-4165(84)90060-6_BIB5
  publication-title: J. Natl. Can. Inst.
  doi: 10.1093/jnci/60.6.1313
– volume: 417
  start-page: 55
  year: 1975
  ident: 10.1016/0304-4165(84)90060-6_BIB2
  publication-title: Biochim. Biophys. Acta
– volume: 40
  start-page: 3559
  year: 1980
  ident: 10.1016/0304-4165(84)90060-6_BIB11
  publication-title: Cancer Res.
– volume: 166
  start-page: 469
  year: 1975
  ident: 10.1016/0304-4165(84)90060-6_BIB24
  publication-title: J. Am. Vet. Med. Assoc.
– volume: 187
  start-page: 185
  year: 1973
  ident: 10.1016/0304-4165(84)90060-6_BIB25
  publication-title: J. Pharmacol. Exp. Therap.
– volume: 793
  start-page: 133
  year: 1984
  ident: 10.1016/0304-4165(84)90060-6_BIB10
  publication-title: Biochim. Biophys. Acta
  doi: 10.1016/0005-2760(84)90314-X
– volume: 33
  start-page: 394
  year: 1973
  ident: 10.1016/0304-4165(84)90060-6_BIB17
  publication-title: Cancer Res.
– volume: 11
  start-page: 181
  year: 1970
  ident: 10.1016/0304-4165(84)90060-6_BIB6
  publication-title: FEBS Lett.
  doi: 10.1016/0014-5793(70)80523-3
– volume: 18
  start-page: 27
  year: 1977
  ident: 10.1016/0304-4165(84)90060-6_BIB27
– volume: 12
  start-page: 186
  year: 1931
  ident: 10.1016/0304-4165(84)90060-6_BIB21
  publication-title: Arch. Pathol.
– volume: 37
  start-page: 911
  year: 1977
  ident: 10.1016/0304-4165(84)90060-6_BIB29
  publication-title: Cancer Res.
– volume: 28
  start-page: 204
  year: 1973
  ident: 10.1016/0304-4165(84)90060-6_BIB30
  publication-title: Oncology
  doi: 10.1159/000224817
– volume: 417
  start-page: 175
  year: 1975
  ident: 10.1016/0304-4165(84)90060-6_BIB4
  publication-title: Biochim. Biophys. Acta
– volume: 193
  start-page: 265
  year: 1951
  ident: 10.1016/0304-4165(84)90060-6_BIB23
  publication-title: J. Biol. Chem.
  doi: 10.1016/S0021-9258(19)52451-6
– volume: 6
  start-page: 39
  year: 1979
  ident: 10.1016/0304-4165(84)90060-6_BIB13
  publication-title: Cancer Lett.
  doi: 10.1016/S0304-3835(79)80018-X
– volume: 60
  start-page: 1329
  year: 1978
  ident: 10.1016/0304-4165(84)90060-6_BIB9
  publication-title: J. Natl. Can. Inst.
  doi: 10.1093/jnci/60.6.1329
– volume: 12
  start-page: 385
  year: 1974
  ident: 10.1016/0304-4165(84)90060-6_BIB14
  publication-title: Adv. Enzyme Reg.
  doi: 10.1016/0065-2571(74)90023-5
– volume: 194
  start-page: 906
  year: 1976
  ident: 10.1016/0304-4165(84)90060-6_BIB1
  publication-title: Science
  doi: 10.1126/science.185697
– start-page: 185
  year: 1971
  ident: 10.1016/0304-4165(84)90060-6_BIB28
  publication-title: Tox. Appl. Pharmacol.
  doi: 10.1016/0041-008X(71)90328-0
– volume: 9
  start-page: 157
  year: 1978
  ident: 10.1016/0304-4165(84)90060-6_BIB3
  publication-title: J. Supramol. Struct.
  doi: 10.1002/jss.400090203
– volume: 271
  start-page: 71
  year: 1978
  ident: 10.1016/0304-4165(84)90060-6_BIB19
  publication-title: Nature
  doi: 10.1038/271071a0
– volume: 27
  start-page: 1702
  year: 1967
  ident: 10.1016/0304-4165(84)90060-6_BIB20
  publication-title: Cancer Res.
– volume: 245
  start-page: 2529
  year: 1970
  ident: 10.1016/0304-4165(84)90060-6_BIB22
  publication-title: J. Biol. Chem.
  doi: 10.1016/S0021-9258(18)63103-5
– volume: 16
  start-page: 3
  year: 1978
  ident: 10.1016/0304-4165(84)90060-6_BIB16
  publication-title: Adv. Enzyme Reg.
  doi: 10.1016/0065-2571(78)90064-X
– volume: 30
  start-page: 2930
  year: 1970
  ident: 10.1016/0304-4165(84)90060-6_BIB8
  publication-title: Cancer Res.
– volume: 253
  start-page: 567
  year: 1975
  ident: 10.1016/0304-4165(84)90060-6_BIB18
  publication-title: Nature
  doi: 10.1038/253567a0
– volume: 40
  start-page: 3921
  year: 1980
  ident: 10.1016/0304-4165(84)90060-6_BIB12
  publication-title: Cancer Res.
– volume: 11
  start-page: 159
  year: 1975
  ident: 10.1016/0304-4165(84)90060-6_BIB26
  publication-title: Mol. Pharmacol.
– volume: 182
  start-page: 935
  year: 1973
  ident: 10.1016/0304-4165(84)90060-6_BIB7
  publication-title: Science
  doi: 10.1126/science.182.4115.935
SSID ssj0000595
ssj0025309
Score 1.3298786
Snippet Three enzymatic activities associated with pyrimidine nucleotide biosynthesis were monitored at weekly or bi-weekly intervals during 2-acetylaminofluorene-...
SourceID proquest
pubmed
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 194
SubjectTerms 2-Acetylaminofluorene
Acetaminophen - toxicity
Acetylaminofluorene
Animals
Carbon-Nitrogen Ligases
Carcinogenesis (Rat liver)
Dihydroorotate Oxidase - metabolism
Ligases - metabolism
Liver Neoplasms, Experimental - chemically induced
Liver Neoplasms, Experimental - enzymology
Liver Regeneration
Male
Nucleoside-Diphosphate Kinase - metabolism
Pyrimidine nucleotide synthesis
Pyrimidine Nucleotides - biosynthesis
Rats
Rats, Inbred F344
Sialoglycoconjugate change
Starvation - metabolism
Title Cyclic modulation of enzymes of pyrimidine nucleotide biosynthesis precedes sialoglycoconjugate changes during 2-acetylaminofluorene-induced hepatocarcinogenesis in the rat
URI https://dx.doi.org/10.1016/0304-4165(84)90060-6
https://www.ncbi.nlm.nih.gov/pubmed/6331524
https://www.proquest.com/docview/81165244
Volume 800
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF6FVgguCAoV4bkHkECWgx_rzfoYBaqIAkKoFb1Z9npNjVI7SuyD-5v4iRyYya7tAGlLuViW116vNJ9nvhnPzhDyInSkzMaxtJMgEzYL4VMMZeDYacATP2ApH3u4G_njJz47Zu9PgpPB4OdG1lJdJSN5vnVfyf9IFa6BXHGX7DUk200KF-Ac5AtHkDAc_0nG00ZijeqzMjVNuJD6qeK8OdOlZBcNNu1KkUgWWLe4rPJUWUlerpoCiB_WIlmAxlMp3L7KMYwzb0BBlsX3GqNrZlfwqt3L6NmxVFUDGMqLMpvXJZbDtMGprzGJ4BQMWwWWcSlh9Buq0HzVZlECzH77e5yX8jTHQgWWqnA9Or4SY2WPeNSWwrZWdYJRop719_klJkxkfRh1IaK4bQq_TtO3Pncjb9XBUmltiI3iC2vSDc1UDvTY9PtcpypbB6M-EOKGgq0jrM6GvvQdZgO_DDaVu3CcDRR7G6ra1c2VjdX3dEjlL4OiYxvd1MD6BXuJJtzh4Hb3RrRNHPjDtnYZj20yHc4U4UyRYNF6lojfILseODmgpXcnh1--HvZMIlh3Dere3m79dPmb7torwV6b1VxErS5yndYU6uguuWN8HzrRQL5HBqrYIzd1N9Rmj9yats0H75MfGtq0hzYtM2qgjac9tGkPbboJbdpCm26BNjXQphra9FJo023QpnlB4UUUoP2AHB-8O5rObNNYxJZ-MK5sLkExpck45TJJY3DovXGKnnWQhSIDl0l63BOeTFyWJMD4uVS-SmIYkVnG41D5-2SnKAv1kFDuyjALYxYI6TAmpBAumMHYd2B-N3W9IfFbmUTSVN3H5i_z6DJEDIndPbXQVWeuuH_cijsyzFkz4ghwfMWTz1t0RCBi_FsYF6qsV5HAwlxA_odkX4OmWwn3fWD97NE1F_mY3O4_2ydkp1rW6ikw-ip5ZoD_C7wN-h0
linkProvider Library Specific Holdings
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Cyclic+modulation+of+enzymes+of+pyrimidine+nucleotide+biosynthesis+precedes+sialoglycoconjugate+changes+during+2-acetylaminofluorene-induced+hepatocarcinogenesis+in+the+rat&rft.jtitle=Biochimica+et+biophysica+acta.+General+subjects&rft.au=Elliott%2C+William+L.&rft.au=Sawick%2C+David+P.&rft.au=DeFrees%2C+Shawn+A.&rft.au=Heinstein%2C+Peter+F.&rft.date=1984-07-30&rft.issn=0304-4165&rft.volume=800&rft.issue=2&rft.spage=194&rft.epage=201&rft_id=info:doi/10.1016%2F0304-4165%2884%2990060-6&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_0304_4165_84_90060_6
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0304-4165&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0304-4165&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0304-4165&client=summon